Malignant neoplasm of liver, not specified as primary or secondary. C22. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C22.
ICD-10 code: C78. 7 Secondary malignant neoplasm of liver and intrahepatic bile duct.
ICD-10-CM Code for Liver cell carcinoma C22. 0.
A type of adenocarcinoma and the most common type of liver tumor.
Primary liver cancer is classified to ICD-9-CM code 155.0. Secondary liver cancer, also called metastasis to the liver, is classified to code 197.7. If liver cancer is documented with no further specification stating primary or secondary, assign code 155.2.
If the site of the primary cancer is not documented, the coder will assign a code for the metastasis first, followed by C80. 1 malignant (primary) neoplasm, unspecified. For example, if the patient was being treated for metastatic bone cancer, but the primary malignancy site is not documented, assign C79. 51, C80.
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection.
ICD-10-CM Code for Liver disease, unspecified K76. 9.
7 for Secondary malignant neoplasm of liver and intrahepatic bile duct is a medical classification as listed by WHO under the range - Malignant neoplasms .
Most cancerous tumors in the liver are metastatic. Types of malignant liver cancer tumors include: Hepatocellular carcinoma or hepatocellular cancer Known as HCC, this is the most common form of liver cancer in adults.
Hepatocellular Carcinoma (HCC) is the major form of liver cancer. Risk factors for HCC include chronic HBV (hepatitis B virus) and HCV (hepatitis C virus) infections, autoimmune hepatitis, chronic alcohol use, obesity and diabetes mellitus etc [2].
In this edition, in addition to the conventional HCC, the WHO recognized 5 morphological subtypes of HCC: Fibrolamellar HCC (FL-HCC), scirrhous HCC (S-HCC), undifferentiated carcinoma, lymphoepithelioma-like carcinoma and sarcomatoid HCC.